These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 39158195)

  • 21. Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditis.
    Duncan CJ; Barr DA; Ho A; Sharp E; Semple L; Seaton RA
    J Antimicrob Chemother; 2013 Jul; 68(7):1650-4. PubMed ID: 23475647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enterococcal endocarditis management and relapses.
    Garofoli N; Joly V; Le Pluart D; Hobson CA; Beaumont AL; Lariven S; Grall N; Para M; Yazdanpanah Y; Lescure FX; Peiffer-Smadja N; Deconinck L; Thy M
    JAC Antimicrob Resist; 2024 Apr; 6(2):dlae033. PubMed ID: 38449516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of dalbavancin with standard of care in the management of infective endocarditis: efficacy, safety, and cost analysis.
    Suárez M; Pérez-Landeiro A; Sanjurjo A; Lima O; Sousa A; López A; Martínez-Lamas L; Cabrera X; Rubianes M; Pérez-Rodríguez MT
    Int J Infect Dis; 2024 Jan; 138():41-45. PubMed ID: 37931892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study.
    Chirouze C; Athan E; Alla F; Chu VH; Ralph Corey G; Selton-Suty C; Erpelding ML; Miro JM; Olaison L; Hoen B;
    Clin Microbiol Infect; 2013 Dec; 19(12):1140-7. PubMed ID: 23517406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single center experience of a vancomycin resistant enterococcal endocarditis cohort.
    Forrest GN; Arnold RS; Gammie JS; Gilliam BL
    J Infect; 2011 Dec; 63(6):420-8. PubMed ID: 21920382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of different antibiotic regimens for the treatment of infective endocarditis.
    Martí-Carvajal AJ; Dayer M; Conterno LO; Gonzalez Garay AG; Martí-Amarista CE; Simancas-Racines D
    Cochrane Database Syst Rev; 2016 Apr; 4():CD009880. PubMed ID: 27092951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.
    Pericas JM; Cervera C; del Rio A; Moreno A; Garcia de la Maria C; Almela M; Falces C; Ninot S; Castañeda X; Armero Y; Soy D; Gatell JM; Marco F; Mestres CA; Miro JM;
    Clin Microbiol Infect; 2014 Dec; 20(12):O1075-83. PubMed ID: 25040215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outpatient parenteral antimicrobial therapy is safe and effective for the treatment of infective endocarditis: a retrospective cohort study.
    Htin AK; Friedman ND; Hughes A; O'Brien DP; Huffam S; Redden AM; Athan E
    Intern Med J; 2013 Jun; 43(6):700-5. PubMed ID: 23347167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experience with enterococcal meningitis/ventriculitis in children.
    Çay Ü; Alabaz D; Özgür Gündeşlioğlu Ö; Kibar F; Çetin C; Oktay K
    Pediatr Int; 2023; 65(1):e15398. PubMed ID: 36305209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Enterococcal endocarditis: clinical features and therapeutic approach].
    Perrone A; Guida G; Morano CM; Papa L; Schiraldi O
    Recenti Prog Med; 1997 Nov; 88(11):507-12. PubMed ID: 9446153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and clinical outcomes of outpatient parenteral antibiotic therapy for infective endocarditis in Christchurch, New Zealand: A retrospective cohort study.
    Campbell PO; Gallagher K; Dalton SC; Metcalf SCL; Douglas NM; Chambers ST
    Int J Infect Dis; 2023 Sep; 134():172-176. PubMed ID: 37331565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enterococcus faecalis infective endocarditis: a pilot study of the relationship between duration of gentamicin treatment and outcome.
    Dahl A; Rasmussen RV; Bundgaard H; Hassager C; Bruun LE; Lauridsen TK; Moser C; Sogaard P; Arpi M; Bruun NE
    Circulation; 2013 Apr; 127(17):1810-7. PubMed ID: 23543002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Teicoplanin in endocarditis: a multicentre, open European study.
    Lewis PJ; Martino P; Mosconi G; Harding I
    Chemotherapy; 1995; 41(5):399-411. PubMed ID: 8521743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of teicoplanin for enterococcal infections: 63 cases and review.
    Schmit JL
    Clin Infect Dis; 1992 Aug; 15(2):302-6. PubMed ID: 1387808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications for Diagnosis and Treatment of Infective Endocarditis: Eight year Experience of an Infectious Disease Team in a Private Tertiary Care Centre.
    Soman R; Gupta N; Chaudhari P; Sunavala A; Shetty A; Rodrigues C
    J Assoc Physicians India; 2018 Apr; 66(4):22-5. PubMed ID: 30347946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Vitro Synergism of Penicillin and Ceftriaxone against
    Thieme L; Briggs S; Duffy E; Makarewicz O; Pletz MW
    Microorganisms; 2021 Oct; 9(10):. PubMed ID: 34683470
    [No Abstract]   [Full Text] [Related]  

  • 37. Hospital resource use and cost of treatment with linezolid versus teicoplanin for treatment of serious gram-positive bacterial infections among hospitalized patients from South America and Mexico: results from a multicenter trial.
    López H; Li JZ; Balan DA; Willke RJ; Rittenhouse BE; Mozaffari E; Vidal G; Zitto T; Tang T
    Clin Ther; 2003 Jun; 25(6):1846-71. PubMed ID: 12860502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of teicoplanin, administered in two different regimens, in the treatment of experimental endocarditis due to Enterococcus faecalis.
    Pavleas J; Skiada A; Daikos GL; Pefanis A; Giamarellos-Bourboulis E; Kanellakopoulou K; Tsaganos T; Perrea D; Donta I; Karayannakos P; Giamarellou H
    J Chemother; 2008 Apr; 20(2):208-12. PubMed ID: 18467247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Enterococcal endocarditis: clinical and microbiological features of our series].
    Utili R; Tripodi MF; Andreana A; Adinolfi LE; Rosario P; Florio A
    Infez Med; 1996; 4(3):137-42. PubMed ID: 14976434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between Infective Factors and Antibiotic Resistance in
    Arabestani MR; Nasaj M; Mousavi SM
    Chonnam Med J; 2017 Jan; 53(1):56-63. PubMed ID: 28184339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.